The administration of pharmacological doses of oral thiamine utilizes low-affinity transporters to restore intracellular levels, which can correct the megaloblastic anemia and significantly improve diabetes control, potentially eliminating the need for insulin in the early stages of the disease [16]. This evidence concerns the gene INS and diabetes mellitus.